Home › Funds › Tetragon Partners GP Ltd › PHVS

Tetragon Partners GP Ltd position in PHVS

PHARVARIS N V · Health Care

Tetragon Partners GP Ltd reported holding 295,627 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$10.2M, representing 1.67% of its reported portfolio and ranking #13 among its reported holdings. Tetragon Partners GP Ltd has disclosed PHVS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)295.63K sh
Reported value held$10.22M
Portfolio Weight1.67%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's PHVS position evolved

Tetragon Partners GP Ltd first disclosed a stake in PHVS in Q1 2025 at 126,995 shares (US$2.0M). The position peaked in Q2 2026 at 295,627 shares, worth US$10.2M. Across 6 filings, Tetragon Partners GP Ltd increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 295,627 shares valued at US$10.2M — an increase of 74,016 shares quarter over quarter.. Notable position changes include a 48% increase in Q2 2025 (shares rose 42% over the following quarter), a 33% increase in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 127.00K $1.99M New
Q2 2025 188.10K $3.31M Add
Q3 2025 194.61K $4.86M Add
Q4 2025 194.61K $5.40M Hold
Q1 2026 221.61K $6.26M Add
Q2 2026 295.63K $10.22M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Tetragon Partners GP Ltd held PHVS?

Tetragon Partners GP Ltd has disclosed PHVS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Tetragon Partners GP Ltd's current position in PHVS?

As of Q2 2026, Tetragon Partners GP Ltd holds 295.63K shares of PHVS (PHARVARIS N V), valued at $10.22M, representing 1.67% of its reported portfolio and ranking #13.

Has Tetragon Partners GP Ltd been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in PHVS. The position peaked in Q2 2026 at 295.63K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.